Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)

China · Delayed Price · Currency is CNY

31.20

+0.13 (0.42%)

At close: May 12, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals		30.09M	1.21M	475.24K	39.19M	1.09M
Pharmaceuticals Growth		2384.10%	154.92%	-98.79%	3502.99%	3393.88%
Total		30.09M	1.21M	475.24K	39.19M	1.09M
Total Growth		2384.10%	154.92%	-98.79%	3502.99%	3393.88%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China		30.09M	1.21M	475.24K	39.19M	1.09M
China Growth		2384.10%	154.92%	-98.79%	3502.99%	3393.88%
Total		30.09M	1.21M	475.24K	39.19M	1.09M
Total Growth		2384.10%	154.92%	-98.79%	3502.99%	3393.88%

Source: S&P Global Market Intelligence.